- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | It's Time We Reframe Healthcare Organizational Culture Using Behavioral Science | ||
| Fr | Hospitals' Cost Containment Conundrum | ||
| Fr | AMA: PBM Market Concentration Is On the Rise | ||
| 01.10. | Sanofi Puts Up $1B to Expand Regeneron Alliance and Develop Next-Gen Dupixent | ||
| 01.10. | The Real Gap in All of Us Isn't Consent, It's Conversion | ||
| 30.09. | FDA Looks to Bring New Scientific, Consumer Voices to Advisory Committees | ||
| 30.09. | MedCity FemFwd: Opportunities in the Fertility Market | ||
| 30.09. | 4 Notable Health Tech Funding Announcements in September | ||
| 30.09. | AI's Healthcare 'Doomsday'? It May Be Less About Autonomy Than Trust | ||
| 30.09. | AI Won't Fix Social Care, But Could It Help Us Finally Make It Work? | ||
| 30.09. | Tiny Health Secures $33M to Expand Microbiome Testing | ||
| 29.09. | Unite Us, Instacart Link Care Coordination and Grocery Benefits to Scale Food-as-Medicine | ||
| 29.09. | AstraZeneca Places a $2B Bet on a Summit Therapeutics Cancer Drug | ||
| 29.09. | MedCity Pivot Podcast: A Conversation With AliveCor's Priya Abani | ||
| 29.09. | The Illegal Drug Marketplace in Your Patients' Pockets | ||
| 29.09. | DreaMed Wins FDA Clearance for CGM-Driven Insulin Automation Tool for Both Type 2 Injection Regimens | ||
| 29.09. | New Coalition Launches to Expand Direct Contracting | ||
| 28.09. | Merck Pays $400M for Cancer Drug Prospect From China-Based SciBrunch | ||
| 28.09. | Beyond One-Size-Fits-All: Women, Substance Use, and the Need for Gender-Responsive Care | ||
| 28.09. | Hospital and Payer AI Governance Is at a Crossroads | ||
| 27.09. | Mirum Pharma Pill Lands FDA Approval for Ultra-Rare Bone Growth Disorder | ||
| 27.09. | When AI Gets Medicine Wrong, Who's Liable? | ||
| 27.09. | Fifty Years of Pediatric Rheumatology, but Children Still Can't Access the Treatments They Need | ||
| 27.09. | MedTech Commercialization Gap: Moving Beyond Technical Viability | ||
| 25.09. | Gene Silencing-Biotech ADARx Makes Some Noise With $535M Stock Market Debut |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.